Anticancer drug discovery using chemical genomics

Current Medicinal Chemistry

Volumn 10, Issue 9, 2003, Pages 749-755

  Sehgal, Anil ^a  

^a ChemGenex Therapeutics Inc   (United States)

Author keywords

Biology; Cancer; Chemical genomics; Chemistry; Drugs; Genomics; Proteomics; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE; DNA; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN; HISTONE DEACETYLASE; IMATINIB; MATRIX METALLOPROTEINASE; NEW DRUG; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; BIOINFORMATICS; CELL ASSAY; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMBINATORIAL CHEMISTRY; DNA MICROARRAY; DRUG POTENCY; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; GENE TARGETING; GENE TECHNOLOGY; GENOMICS; HUMAN; PROTEOMICS; REVIEW; RISK ASSESSMENT; TIME; VALIDATION PROCESS;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; NEOPLASMS; PROTEOMICS;

EID: 0037265607     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033457764     Document Type: Review

References (40)

1. Schwartsmann, G.; Ratain, M.J.; Cragg, G.M.; Wong, J.E.; Saijo, N.; Parkinson, D.R.; Fujiwara, Y.; Pazdur, R.; Newman, D.J.; Dagher, R.; Di Leone, L. J. Clin. Oncol., 2002, 20, 47.
2. Robert, C. Young. CA. Cancer. J. Clin., 2002, 52, 6.
3. Izraeli, S.; Witz, I.; Micksche, M. Isr. Med. Assoc. J., 200, 4(9), 746.
4. Hahn, W.C.; Weinberg RA. N. Engl. J. Me., 2002, 347, 1593.
5. Laiho, M. Duodecim., 2002, 118, 175.
6. Collins, F.S. Hosp. Pract. (Off Ed)., 1997, 32, 35.
7. Ganguly, N.K.; Bano, R.; Seth, S.D. Indian. J. Exp. Biol., 2001, 39, 955.
8. Untergasser, G.; Koch, H.B.; Menssen, A.; Hermeking, H. Cancer. Res., 2002, 62, 6255.
9. Ye, S.Q.; Usher, D.C.; Zhang, L.Q. J. Biomed. Sci., 2002, 9, 384.
10. Boon, K.; Osorio, E.C.; Greenhut, S.F.; Schaefer, C.F.; Shoemaker, J.; Polyak, K.; Morin, P.J.; Buetow, K.H.; Strausberg, R.L.; De Souza, S.J.; Riggins, G.J. Proc. Natl. Acad. Sci. U S A., 2002, 99, 11287.
11. Hopkins, A.L.; Groom, C.R. Nat. Rev. Drug. Discov., 2002, 1, 727.
12. Drews, J.; Ryser, S. Nature. Biotech., 1997, 15, 1318.
13. Scagliotti.; G.V. Clinical. trials. Suppl. Tumor, 2002, 1, S34.
14. Violette, S.; Festor, E.; Pandrea-Vasile, I.; Mitchell, V.; Adida, C.; Dussaulx, E.; Lacorte, J.M.; Chambaz, J.; Lacasa, M.; Lesuffleur, T. Int. J. Cancer, 2003, 103, 185.
15. Sanchez-Carbayo, M.; Socci, N.D.; Charytonowicz, E.; Lu, M.; Prystowsky, M.; Childs, G.; Cordon-Cardo, C. Cancer Res., 2002, 62, 6973.
16. Chung, C.H.; Bernard, P.S.; Perou, C.M. Nat. Genet., 2002, 2, 533.
17. Chen, ST.; Pan, T.L.; Tsai, Y.C.; Huang, C.M. Cancer Lett., 2002, 181, 95.
18. Westphal, G.; Burgemeister, R.; Friedemann, G.; Wellmann, A.; Wernert, N.; Wollscheid, V.; Becker, B.; Vogt, T.; Knuchel, R.; Stolz, W.; Schutze, K. Methods Enzymol., 2002, 356, 80.
19. Rai, A.J.; Zhang, Z.; Rosenzweig, J.; Shih, I.M.; Pham, T.; Fung, E.T.; Sokoll, L.J.; Chan, D.W. Arch. Pathol. Lab. Med., 2002, 126, 1518.
20. McCluskey, A.; Sakoff, J. A. Mini. Rev. Med. Chem., 2001, 1, 43.
21. Walker, M.G. Mini. Rev. Med. Chem., 2001, 1, 197.
22. Boland, G.P. Knox WF, Bundred NJ. Microsc. Res. Tech., 2002, 59, 3.
23. George, D.J. Urology, 2002, 60, 115.
24. Advani, A.; Pendergast, A.M. Leuk. Res., 2002, 26, 713.
25. Capdeville, R.; Buchdunger, E.; Zimmermann, J.; Matter, A. Nat. Rev. Drug. Discov., 2002, 1, 493.
26. Gambacorti, C. Tumori., 2001, 87, 10.
27. Weinstein, J.N.; Buolamwini, J.K. Curr. Pharm. Des., 2000, 6, 473.
28. Sehgal, A. Curr. Opin. Drug. Discov. Devel., 2002, 5, 526.
29. Falb, D.; Jindal, S. Curr. Opin. Drug. Discov. Devel., 2002, 5, 532.
30. Isaacson, R.E. Curr. Pharm. Des., 2002, 8, 1091.
31. Pennie, W.D.; Kimber I. Toxicol. In Vitro, 2002, 16, 319.
32. Hamadeh, H.K.; Bushel, P.R.; Jayadev, S.; DiSorbo, O.; Bennett, L.; Li, L.; Tennant, R.; Stoll, R.; Barrett, J.C.; Paules, R.S.; Blanchard, K.; Afshari, C.A. Toxicol. Sci., 2002, 67, 232.
33. Zheng, X.F.; Chan, T.F. Curr. Issues. Mol. Biol., 2002, 4, 33.
34. Morgan, K.T. Toxicol. Sci., 2002, 67, 155.
35. Veber, D.F.; Drake, F.H.; Gowen, M. Curr. Opin. Chem. Biol., 1997, 1,151.
36. Lenz, G.R.; Nash, H.M.; Jindal, S. Drug. Discov. Today, 2000, 5, 145.
37. Nuwaysir, E.F.; Bittner, M.; Trent, J.; Barrett J.C.; Afshari, C.A. Mol. Carcinog., 1999, 24, 153.
38. Waring, J.F.; Ulrich, R.G. Annu. Rev. Pharmacol. Toxicol., 2000, 40, 335.
39. Ballatori, N.; Villalobos, A.R. Toxicol. Appl. Pharmacol., 2002, 183, 207.
40. Fredrickson, H.L.; Perkins, E.J.; Bridges, T.S.; Tonucci, R.J.; Fleming, J.K.; Nagel, A.; Diedrich, K.; Mendez-Tenorio, A.; Doktycz, M.J.; Beattie, K.L. Sci. Total. Environ., 2001, 274, 137.